SUZ12 and ovarian carcinoma: Previous studies have revealed that SUZ12 expression associates with patients’ prognosis and is identified as a key independent prognostic predictor for patients with epithelial ovarian cancer, non-small cell lung cancer and gastric cancer [12, 13].